We are live on ! Find out more
NBP icon

NovaBridge Biosciences American Depositary Shares

49 hedge funds and large institutions have $72.1M invested in NovaBridge Biosciences American Depositary Shares in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,700% more call options, than puts

Call options by funds: $98K | Put options by funds: $1K

7% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 15

3.37% less ownership

Funds ownership: 28.8% → 25.43% (-3.4%)

14% less funds holding

Funds holding: 57 → 49 (-8)

47% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 17

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

58% less capital inflows, than outflows

Capital inflows: $10.6M | Capital outflows: $25.3M

Holders
49
Holders Change
-8
Holders Change %
-14.04%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
9
Increased
14
Reduced
15
Closed
17
Calls
$98​K
Puts
$1​K
Net Calls
+$97​K
Net Calls Change
+$179​K

NBP Hedge Fund Activity: Q1 2026 in Review

49 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2026, worth a combined $72.1M — down 45% from $132M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of NBP and 9 opened new positions — a net loss of 8 holders — while 15 trimmed existing stakes and 14 added.

The largest buyer was AIHC Capital Management, adding an estimated $6.19M. The largest seller was Janus Henderson Group, cutting an estimated $8.05M.

  • 49 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2026, down from 57 in Q4 2025.
  • Funds reported $72.1M of NovaBridge Biosciences American Depositary Shares stock for Q1 2026, down 45% quarter-over-quarter.
  • 9 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2026 and 17 closed out, a net change of -8 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2026 was AIHC Capital Management, an estimated $6.19M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2026 was Janus Henderson Group, an estimated $8.05M sold.

Based on aggregated 13F filings for Q1 2026.